跳至主要内容
临床试验/NCT05325749
NCT05325749Unknown不适用

Development of the Technology and Methodology for Generation of the Genetic Passport (Genetic Health Record) of Newborn and Application Thereof to Estimate the Mid and Low Penetrance Hereditary Disorders Frequencies in Russian Population and to Uncover Genetic Factors Determining Severe Monogenic Conditions

Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare1 个研究点 分布在 1 个国家目标入组 7,000 人开始时间: 2021年7月10日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
7,000
试验地点
1
主要终点
Phenotype-associated variants

研究概览

简要总结

The aim of the study is to obtain the initial experience of the inclusive genetic screening of newborn.

Two groups of newborns born in RCOGP will be enlisted to the study:

  1. newborns without developmental features having no variations according to an inherited diseases screening;
  2. newborns showing either phenotypic features or deviations according to MS screening.

The residual volume of the cord blood of all newborns form both groups will be collected and subjected to the whole exome sequencing. The sequencing data will be analyzed in "screening" mode for the first group while for the second group analysis will be performed taking the respective phenotype into account.

The study is planned to cover 7000 newborns in total.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

性别
All
接受健康志愿者

入选标准

  • Infants born in the RCOGP, showing no development features and with no inherited diseases revealed by common screening
  • Informed consent signed by a newborn's representative

排除标准

  • Parents refuse to participate
  • Parent(s) younger 18 years
  • Parent(s) unable to make decisions
  • The infant is older 30 d
  • Blood cannot be collected from the infant
  • Group 2 (newborns with phenotypic features)
  • Inclusion Criteria:
  • Infants showing either phenotypic features or deviations according to MS screening
  • Informed consent signed by a newborn's representative
  • Exclusion Criteria:
  • Parents refuse to participate
  • Parent(s) younger 18 years
  • Parent(s) unable to make decisions
  • Blood cannot be collected from the infant
  • Detailed description of the phenotype is not available
  • The infant's exome has been already sequenced

结局指标

主要结局

Phenotype-associated variants

时间窗: 2 weeks - 2 months

Pathogenic, likely pathogenic variants or variants of uncertain significance corresponding to the observed clinical conditions

Motivations for refuse to participate

时间窗: 1 day

Questionnaire answers provided by families refused to enroll

Estimate the frequency of revealing patients carrying genotype associated with a monogenic disese.

时间窗: 3-5 months

The manifestation of pathogenic or likely pathogenic variants leading to a monogenic disease presenting during early age. A genotype is considered having risk of developping a monogenic disease in case pathogenic or probably pathogenic variants are detected corresponding to the inheritance model.

Acceptance of advanced screening

时间窗: 1 day

Questionnaire answers provided by families accepted screening for variants of low penetrance, no care available etc.

次要结局

  • Oncological risk(1 day)
  • Cardiological risk(1 day)
  • Recessive carriers(1 day)

研究者

发起方
Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare
申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Whole Exome Screening of Newborns | 临床试验